Author:
İMRE Burcu,İMRE YETKİN Duygu,GÜLERMAN Cavidan
Publisher
Ministry of Health, Ankara City Hospital
Reference24 articles.
1. REFERENCES:
1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and sterility 2009; 91(2):456-88.
2. 2. Aktaran Ş, Akarsu E, Çelik A, Altunören O. Polikistik over sendromunda obeziteden bağımsız olarak artmış plazma homosistein düzeylerinin insülin rezistansı ile korelasyonu. Turkiye Klinikleri Journal of Medical Sciences 2007; 27(4):508-12.
3. 3. ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility 2004; 81(1):19-25.
4. 4. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction 2018; 33(9):1602-18.
5. 5. Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013; 170(1):157-61.